Yang Min, Huang Haichang, Li Jingzi, Huang Wen, Wang Haiyan
Division of Nephrology, Peking University First Hospital, Beijing, China.
Wound Repair Regen. 2007 Nov-Dec;15(6):817-24. doi: 10.1111/j.1524-475X.2007.00284.x.
The involvement of gelatinase (matrix metalloproteinase-2 [MMP-2] and MMP-9) in the matrix remodeling and development of tubulointerstitial fibrosis has been studied recently, but relatively little is known about the regulators and the mechanisms controlling the activation and expression of gelatinase in renal fibroblasts. In these studies, the production and underlying signaling pathway for gelatinase by exogenous connective tissue growth factor (CTGF) treatment were investigated. Here, we show that CTGF acts as a potent promoter of the activation and expression of MMP-2, but not MMP-9 in normal rat kidney fibroblasts cell line (NRK-49F). We found that CTGF significantly increased the activity of MMP-2, as well as MMP-2 protein in conditioned medium and MMP-2 mRNA levels in cells. In studies to address the mechanisms involved in the regulation of MMP-2 activity, we found that the tissue inhibitor of matrix metalloproteinase-2 (TIMP-2), the inhibitor of MMP-2, decreased significantly when cells were treated with CTGF. Further studies showed that extracellular signal-regulated kinase (ERK) signaling is responsible for most of the CTGF-induced MMP-2 expression and TIMP-2 suppression. When NRK-49F fibroblasts were incubated with CTGF, activation of ERK1/2 signaling was observed. Suppression of ERK1/2 activation with nontoxic concentrations of PD98059, a specific inhibitor of ERK activation, was associated with a reduction of CTGF-stimulated MMP-2 activity and protein expression. In addition, the CTGF-mediated reduction of TIMP-2 activity and protein expression was prevented when ERK1/2 activation was inhibited by PD98059. These results provide evidence that CTGF augments activation of MMP-2 through an effect on MMP-2 protein expression and TIMP-2 suppression, and that these effects are dependent on the activation of the ERK1/2 pathway.
明胶酶(基质金属蛋白酶-2 [MMP-2] 和 MMP-9)在肾小管间质纤维化的基质重塑和发展中的作用最近已得到研究,但对于肾成纤维细胞中明胶酶激活和表达的调节因子及机制却知之甚少。在这些研究中,对外源性结缔组织生长因子(CTGF)处理后明胶酶的产生及其潜在信号通路进行了研究。在此,我们表明CTGF在正常大鼠肾成纤维细胞系(NRK-49F)中是MMP-2激活和表达的强效促进剂,但对MMP-9并非如此。我们发现CTGF显著增加了MMP-2的活性,以及条件培养基中的MMP-2蛋白和细胞中的MMP-2 mRNA水平。在探讨MMP-2活性调节机制的研究中,我们发现当细胞用CTGF处理时,MMP-2的组织抑制剂基质金属蛋白酶组织抑制剂-2(TIMP-2)显著降低。进一步研究表明,细胞外信号调节激酶(ERK)信号传导是CTGF诱导的MMP-2表达和TIMP-2抑制的主要原因。当NRK-49F成纤维细胞与CTGF一起孵育时,观察到ERK1/2信号的激活。用无毒浓度的PD98059(一种ERK激活的特异性抑制剂)抑制ERK1/2激活与CTGF刺激的MMP-2活性和蛋白表达的降低有关。此外,当ERK1/2激活被PD98059抑制时,CTGF介导的TIMP-2活性和蛋白表达的降低被阻止。这些结果提供了证据,表明CTGF通过对MMP-2蛋白表达和TIMP-2抑制的作用增强MMP-2的激活,并且这些作用依赖于ERK1/2途径的激活。